stockrow
Friday 6 November 2026
Export USNA’s income statement to Excel — free account
USANA Health Sciences, Inc.
USNA Consumer Defensive Packaged Foods
USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024.
- Revenue
- −3.64%
- EPS
- −3.47%
- Free cash flow
- +180.6%
Quarter to September 2026, against a year earlier
13.58
0.28
−2.02%
Follow USNA
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
16.13 | 29.74 | 23.04 | 17.77 | 13.16 | 17.72 | 15.17 | 16.50 | 16.31 | 35.69 |
Piotroski F-Score |
6 | 6 | 9 | 5 | 7 | 6 | 6 | 7 | 6 | 7 |
Altman Z-Score |
10.36 | 11.03 | 15.05 | 10.72 | 8.91 | 10.98 | 7.46 | 8.06 | 4.46 | 3.59 |
P/S ratio |
1.50 | 1.74 | 2.39 | 1.68 | 1.44 | 1.72 | 1.05 | 1.14 | 0.80 | 0.39 |
Altman Z″-Score (non-manufacturers) |
8.11 | 8.48 | 9.62 | 8.52 | 8.76 | 8.52 | 8.81 | 10.23 | 6.49 | 6.46 |
P/FCF ratio |
14.44 | 16.50 | 20.12 | 16.14 | 11.22 | 18.79 | 11.21 | 18.66 | 13.45 | 29.27 |
P/Operating CF |
27.28 | 33.10 | 70.20 | 31.91 | 34.04 | 81.81 | 25.91 | 40.28 | 118.51 | (107.33) |
P/B ratio |
4.62 | 5.02 | 7.26 | 5.06 | 3.69 | 5.16 | 2.41 | 2.11 | 1.29 | 0.68 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 70 |
Price to Tangible BV |
5.49 | 5.87 | 8.29 | 5.83 | 4.15 | 5.88 | 2.73 | 2.33 | 2.90 | 1.39 |
EV/Sales |
1.39 | 1.57 | 2.21 | 1.52 | 1.22 | 1.57 | 0.83 | 0.85 | 0.67 | 0.29 |
EV/EBITDA |
9.17 | 11.06 | 12.80 | 9.51 | 6.96 | 9.69 | 6.40 | 6.91 | 6.44 | 3.52 |
EV/Operating CF |
10.19 | 13.28 | 17.26 | 12.70 | 8.64 | 15.38 | 7.95 | 11.09 | 9.34 | 12.15 |
EV/FCF |
13.38 | 14.87 | 18.62 | 14.61 | 9.53 | 17.19 | 8.84 | 13.96 | 11.18 | 21.84 |
Quick Ratio |
1.27 | 1.75 | 1.87 | 1.73 | 1.86 | 1.49 | 2.01 | 2.78 | 1.30 | 1.23 |
Current Ratio |
2.01 | 2.41 | 2.64 | 2.42 | 2.53 | 2.27 | 2.67 | 3.52 | 2.00 | 2.24 |
Net Debt/EBITDA |
(1.16) | (1.66) | (1.35) | (1.39) | (1.57) | (1.25) | (2.24) | (2.91) | (2.05) | (2.05) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
2.25 | 2.12 | 2.22 | 1.98 | 1.96 | 1.95 | 1.70 | 1.50 | 1.24 | 1.24 |
Operating CF/Net income |
1.37 | 1.98 | 1.21 | 1.26 | 1.29 | 1.04 | 1.50 | 1.11 | 1.45 | 2.08 |
Capex/Depreciation |
(2.42) | (0.82) | (0.66) | (0.72) | (0.67) | (0.57) | (0.49) | (0.71) | (0.45) | (0.25) |
Interest Coverage |
312.21 | 2,880.52 | 5,232.03 | 2,215.00 | 348.11 | 2,985.82 | 560.49 | 355.23 | 236.03 | 44.46 |
| 33.01% | 18.17% | 33.47% | 27.06% | 31.43% | 27.85% | 16.72% | 13.69% | 8.17% | 2.02% | |
| 22.38% | 12.63% | 23.51% | 18.77% | 21.53% | 19.12% | 11.81% | 10.38% | 6.09% | 1.44% | |
ROIC |
57.95% | 71.34% | 103.92% | 78.17% | 85.03% | 68.50% | 46.05% | 34.88% | 11.83% | 6.24% |
Return on Tangible Assets |
41.57% | 20.72% | 37.60% | 34.85% | 34.86% | 38.06% | 20.50% | 16.00% | 17.95% | 4.23% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
68.31% | 70.22% | 67.28% | 68.55% | 66.02% | 67.29% | 69.81% | 70.71% | 73.37% | 73.49% |
Intangible Assets out of Total Assets |
0.11 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 | 0.40 | 0.36 |
Share Based Compensation of Revenue |
1.64% | 1.48% | 1.26% | 1.46% | 1.27% | 1.21% | 1.33% | 1.58% | 1.70% | 1.49% |
Graham Net Nets |
0.09 | 0.10 | 0.08 | 0.09 | 0.14 | 0.09 | 0.21 | 0.27 | 0.09 | 0.22 |
Graham Number |
34.16 | 29.08 | 43.19 | 39.30 | 52.46 | 50.20 | 42.69 | 43.79 | 37.13 | 18.87 |
Earnings Yield |
6.20% | 3.36% | 4.34% | 5.63% | 7.60% | 5.64% | 6.59% | 6.06% | 6.13% | 2.80% |
Free Cash Flow Yield |
6.93% | 6.06% | 4.97% | 6.19% | 8.91% | 5.32% | 8.92% | 5.36% | 7.44% | 3.42% |
Revenue per Share |
41.60 | 43.01 | 49.34 | 46.85 | 53.63 | 58.89 | 51.86 | 47.84 | 44.73 | 49.92 |
Operating CF per Share |
5.66 | 5.08 | 6.31 | 5.60 | 7.58 | 6.02 | 5.40 | 3.67 | 3.19 | 1.21 |
Capex per Share |
(1.35) | (0.54) | (0.46) | (0.73) | (0.71) | (0.63) | (0.54) | (0.75) | (0.52) | (0.54) |
Free Cash Flow per Share |
4.31 | 4.54 | 5.85 | 4.87 | 6.87 | 5.38 | 4.86 | 2.92 | 2.67 | 0.67 |
Cash per Share |
7.27 | 10.15 | 11.53 | 10.37 | 14.74 | 11.90 | 14.98 | 17.16 | 9.52 | 8.54 |
Shareholders Equity per Share |
13.45 | 14.92 | 16.23 | 15.53 | 20.88 | 19.61 | 22.57 | 25.83 | 27.85 | 28.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.45 | 14.92 | 16.23 | 15.53 | 20.88 | 19.61 | 22.57 | 25.83 | 27.85 | 28.76 |
Free Cash Flow |
104.20 | 110.58 | 141.07 | 110.18 | 145.31 | 108.48 | 93.51 | 56.16 | 50.98 | 12.43 |
Working Capital |
139.37 | 198.98 | 243.65 | 193.18 | 257.21 | 204.33 | 240.55 | 298.90 | 139.56 | 159.84 |
Capital Expenditures |
(32.69) | (13.20) | (11.05) | (16.55) | (15.09) | (12.75) | (10.39) | (14.48) | (10.01) | (9.92) |
Net Current Asset Value |
132.51 | 184.10 | 229.02 | 164.06 | 226.05 | 182.50 | 222.31 | 282.19 | 63.10 | 78.59 |
EV/EBIT |
10.06 | 12.41 | 13.94 | 11.01 | 7.85 | 10.96 | 7.68 | 8.42 | 8.59 | 7.25 |
Capex to Sales |
0.03 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
10.85 | 13.77 | 15.07 | 12.17 | 9.24 | 11.98 | 9.74 | 11.26 | 10.34 | 9.72 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.16 | 0.18 | 0.24 | 0.22 | 0.22 | 0.22 | 0.20 | 0.24 | 0.42 |
Cash ROIC |
20.80% | 18.12% | 21.09% | 18.78% | 19.28% | 17.08% | 12.94% | 6.79% | 7.14% | 1.80% |
Accounts Receivable Turnover |
65.97 | 68.67 | 86.53 | 93.09 | 140.24 | 162.72 | 138.93 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
18.88 | 17.23 | 18.47 | 16.69 | 13.61 | 13.75 | 15.79 | 16.73 | 14.62 | 13.73 |
Inventory Turnover |
2.75 | 2.81 | 2.77 | 2.49 | 2.63 | 2.31 | 2.34 | 2.75 | 2.46 | 2.33 |
Average Days of Payables |
18.31 | 23.98 | 18.09 | 24.38 | 31.76 | 22.63 | 20.80 | 20.80 | 27.13 | 31.37 |
Days of Inventory on Hand |
131.28 | 128.01 | 149.03 | 134.13 | 157.48 | 164.69 | 126.30 | 126.95 | 157.89 | 186.47 |
Average Receivables |
15.25 | 15.25 | 13.74 | 11.40 | 8.09 | 7.29 | 7.19 | — | — | — |
Average Payables |
9.54 | 10.41 | 10.87 | 11.24 | 15.36 | 15.85 | 12.28 | 10.56 | 11.03 | 14.62 |
Average Inventory |
65.46 | 63.86 | 72.43 | 75.43 | 79.56 | 94.27 | 82.70 | 64.27 | 65.59 | 86.17 |
Average Assets |
446.94 | 494.96 | 536.87 | 535.70 | 578.91 | 609.31 | 587.14 | 614.65 | 690.48 | 745.55 |
Average Common Equity |
303.07 | 344.25 | 377.18 | 371.43 | 396.68 | 418.39 | 414.80 | 465.84 | 514.66 | 532.61 |
Columns are period end dates · fundamentals updated 5 Nov 2026